Shortage Notice: Disopyramide 100mg/150mg capsules

Shortage Notice: Disopyramide 100mg/150mg capsules

June 26, 2019

Sanofi and Mylan, the manufacturers of Disopyramide 100mg and 150mg capsules, are currently experiencing temporary disruptions.

Sanofi and Mylan will be out of stock of Disopyramide 100mg capsules from approximately mid-June 2019 to late-July 2019.

Mylan will be out of stock of the Disopyramide 150mg capsules from approximately mid-August 2019 till mid-September 2019. 

Supplies are available from specialist importers on an ‘unlicensed’ basis. Ensure that where a prescriber wishes you to dispense an import, prescriptions are annotated ‘specials/unlicensed’ and are endorsed as follows:

  • Amount dispensed over pack size used;
  • Invoice price per pack size from which the order was supplied less any discount or rebate;
  • Manufacturers’/importers’ MHRA licence number;
  • Batch number of the product supplied;
  • SP

More information and details of alternative products can be found here on the Supply Disruption Alert

Enquiries about this notice should be sent to the DHSC Supply Resilience Team, quoting reference number SDA/2019/002 or email: 

Posted in: ,

More Latest News >

CPCS Frequently Asked Questions

With the Community Pharmacist Consultation Service (CPCS) now bedding in, below you will find a selection of questions about the...

CPCS: CPD opportunities

As announced in the 5-year CPCF agreement, NHS England & NHS Improvement and Health Education England (HEE) will use funding...